The WisdomTree US LargeCap Dividend Fund ETF (DLN) maintains a buy rating due to its attractive valuation with a price-to-earnings ratio under 18 and a 1.75% dividend yield. DLN focuses on US large-cap dividend-paying stocks, blending value and moderate growth, with top holdings like Microsoft and NVIDIA that offer both stability and growth potential. Despite a weak September for stocks, seasonal trends and strong fourth-quarter outlooks suggest the recent dip is a good buying opportunity for investors seeking a diversified, low-volatility portfolio. This ETF provides exposure to blue-chip companies with reasonable growth prospects, making it appealing amid current market conditions.
Nvidia leads with a market cap of $5.09 trillion, while Microsoft holds $3.75 trillion as of Sep 15, 2026, 22:41 WIB. Microsoft shares are trading at USD 499.59, down 1.15% for the day, and Nvidia is at USD 212.38, up 0.67%. These figures highlight the scale and daily movement of key DLN holdings on Pluang amid the ETF's focus on steady dividend payers.
Apple's stock has risen 28% this year, matching the overall technology sector and outperforming rivals Microsoft and Alphabet. This surge is largely fueled by strong early demand for the new iPhone Duo, which has also boosted Apple's growing services...
The Carillon Eagle Growth & Income Fund lagged behind its S&P 500 benchmark during the third quarter of 2026. Key contributors to the fund's performance included strong gains in Microsoft, driven by robust Azure cloud services and AI demand. Other to...
OpenAI has reduced its valuation target from $1.4 trillion to $1.25 trillion following pushback from private investors, coinciding with a sharp drop in public AI stocks. This $150 billion cut reflects growing investor caution as OpenAI seeks up to $3...
Microsoft's Azure cloud service has surpassed $100 billion in annual revenue, with contracted demand rising 84% to $678 billion, signaling a potential $1 trillion cloud and AI franchise. Despite a recent stock dip, Microsoft beat revenue and earnings...
Microsoft's AI system, MAI-DxO, correctly diagnosed complex medical cases 83% of the time in simulations, more than twice the accuracy of generalist physicians who scored 36%. The system uses multiple AI agents that mimic a panel of doctors to questi...
